Virtual Reality Based Cognitive Behavioral Therapy for Public Speaking Anxiety
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 37
- 试验地点
- 1
- 主要终点
- Public Speaking Anxiety Scale (PSAS), (Bartholomay & Houlihan, 2016).
研究概览
简要总结
This study aims to examine the efficacy of exposure using virtual reality (VR) for public speaking anxiety in young adults in two treatment arms: a one-session VR exposure therapy with a 4-week online transition intervention versus a three-session VR exposure therapy with a 4-week online transition intervention. Previous studies have demonstrated that one-session therapy (OST) is comparable to prolonged exposure-based therapies in terms of effectively reducing public speaking anxiety. Moreover, VR offers many benefits compared to in-person exposure, namely the ability to produce anxiety-evoking stimuli without having to leave the therapist's room. However, OST VR exposure has not been directly compared to prolonged VR exposure and not for public speaking anxiety.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 30 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •aged 18-30 and pursuing higher education;
- •experiencing a significant level of public speaking anxiety (60+ on PSAS);
- •able to use a computer and have access to the internet for the duration of the study;
- •able to understand, write and speak in Lithuanian;
- •available to participate in one or three in-person intervention sessions and can devote the time to participate in a 4-week online program following the intervention sessions.
排除标准
- •a history of seizures or a history of epilepsy;
- •other significant medical conditions that would prevent them from participating in the program;
- •high levels of depression (Patient Health Questionnaire-9 rating of 15 and above and mentions of suicidal ideation) or other significant psychiatric conditions that would interfere with participation in the program;
- •a tendency to have extreme seasickness reactions or a history of adverse physical reactions to virtual reality experiences or difficulty with or lack of stereoscopic vision;
- •current involvement in other psychological interventions such as psychological counseling or psychotherapy;
- •use of psychoactive drugs, unless stable for three months;
- •current participation in other programs aimed at reducing public speaking anxiety.
研究组 & 干预措施
One session therapy
One session exposure therapy followed by 4 weeks of internet-delivered self-help with therapist support on demand
干预措施: Exposure in virtual reality and text based cognitive behavioral therapy (CBT) for public speaking anxiety (Behavioral)
One session therapy - divided into 3
Three session exposure therapy followed by 4 weeks of internet-delivered self-help with therapist support on demand
干预措施: Exposure in virtual reality and text based cognitive behavioral therapy (CBT) for public speaking anxiety (Behavioral)
结局指标
主要结局
Public Speaking Anxiety Scale (PSAS), (Bartholomay & Houlihan, 2016).
时间窗: Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment
Canonical total score will be used. Measure is self-rated, online. The scale consists of 17 self-report statements measured on a Likert-type scale ranging from 1 "not at all", to 5 "extremely". A higher score indicates higher levels of experienced public speaking anxiety.
Public Speaking Anxiety Scale (PSAS).
时间窗: Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment
Canonical total score will be used. Measure is self-rated, online. The scale consists of 17 self-report statements measured on a Likert-type scale ranging from 1 "not at all", to 5 "extremely". A higher score indicates higher levels of experienced public speaking anxiety.
次要结局
- Patient health questionnaire - 9 (PHQ-9), (Spitzer et al., 1999)(Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment)
- Brief Fear of Negative Evaluation Scale (BFNE), (Leary, 1983)(Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment)
- Igroup Presence Questionnaire (IPQ)(Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment)
- Liebowitz Social Anxiety Scale - Self-Report (LSAS-SR), (Liebowitz, 2003; Rytwinski et al., 2009)(Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment)
- Liebowitz Social Anxiety Scale - Self-Report (LSAS-SR)(Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment)
- Brief Fear of Negative Evaluation Scale (BFNE)(Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment)
研究者
Jonas Eimontas
Associate Professor, Senior Research Fellow
Vilnius University